Category: Sectorial: Health Technology

A group of state attorneys general has reached an agreement with Johnson & Johnson and three drug distributors this Wednesday to pay a penalty of $ 26 billion for fueling an opioid epidemic in the US, according to 'CNBC'.…

The most normal thing is that we can end up seeing an extension of the increases to the level of 9,500 pointsTechnical analysisSECURITIES IN A BULL TREND Acerinox It is one of the values ​​that we do not lose sight of since…

US President Joe Biden announced on Thursday afternoon a new goal of injecting 200 million coronavirus vaccines in his first 100 days in office. He has stated it in the first press conference he has given as president."Today I…

Oryzon went through the confessional this Monday. The biotech company has declared losses of 3.4 million euros in 2020, a figure that represents a reduction of 7.7% compared to the same period of the previous year. The company has…

For the next few days it seems very likely that we could end up seeing an extension of the gains in the selective Spanish to the level of 9,000 points. With this very favorable outlook on the Ibex 35, we have selected three stocks that…

It is important that the Spanish selective does not abandon the support of 8,000 pointsTechnical analysisBREAKING RESISTANCE Rovi Laboratories it has managed to pierce the resistance of 43.8 euros, which allows it to move…

Oryzon Genomics It rises 10.28% which allows it to pierce the resistance of 2,875 euros. Be aware that we could end up seeing an extension of the rises to the level of 3.20 euros. Let us advise you on your investments. Try Trader Watch…

The most normal thing is that it continues to gain positionsTechnical analysisSECURITIES IN A BULL TREND The increases in recent days bring the price of Johnson & Johnson to the top of the lateral movement in which the…

Below the first level of support in the selective Spanish is at 6,763 pointsTechnical analysisBREAKING RESISTANCE Attentive to the end of the lateral consolidation of the last sessions in Rovi. The company rises 4.82% which…

Moderna's vaccine schedule continues its course. Rovi has confirmed this Tuesday that it will start manufacturing millions of doses for the American company from the beginning of 2021: "Fortunately, Moderna's vaccine…